GW Biorepository Now a Core Facility

August 2, 2019

The George Washington University (GW) is pleased to announce that the GW Biorepository is now a core facility. Housed at the GW School of Medicine and Health Sciences, the GW Biorepository received designation as a shared resource available to all GW investigators and is accredited by the College of American Pathologists.

The GW Biorepository is a comprehensive, state-of-the-art resource for bio-specimen processing, storage, and disbursement designed to help today's leading investigators facilitate their research. In existence since 1994, the GW Biorepository is funded by the National Cancer Institute and includes 100,000 specimens from various NIH-funded cooperative projects, including the AIDS and Cancer Specimen Resource, the AIDS Malignancy Consortium, Women's Interagency HIV Study, and START Insight.

The facility's director, Sylvia Silver, DA, and associate director, Jeffrey Bethony, PhD, both professors of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, can be contacted for more information and costs at and The GW Biorepository is located in Ross Hall, rooms 118 and 119. It is electronically monitored to ensure proper environmental conditions for specimens.

Much of the infrastructure to support GW research is organized in scientific cores meant to facilitate discovery. These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research. In addition to the GW Biorepository, shared resources available to all GW investigators, often for a fee-for-service charge, include:

For more information on the GW Biorepository, visit

This announcement was provided by the GW School of Medicine and Health Sciences.

Latest News

January 26, 2022
Announcement (Jan. 26, 2022) — The George Washington University (GW) is pleased to announce that Julie E. Bauman, MD, MPH, will join its academic medical enterprise to serve as the director of the GW Cancer Center. In this role, Bauman will build on the momentum of the last five years to enhance…
September 9, 2021
For patients diagnosed with skin cancer, particularly basal cell and squamous cell carcinoma, one of the best treatment options can be Mohs surgery, a tissue-sparing, tumor-removal procedure.
September 2, 2021
GW Radiation Oncology is pleased to share the 2021 Annual Report, a summary of our efforts to adapt to the COVID-19 pandemic, address health disparities, and improve diversity and inclusion.